GlassScriptPhysician profile
Thomas Brett Davis
NPI 1831198704
$5,596.64
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,628 · 2022: $970 · 2023: $1,180 · 2024: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926 · Education: $73.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,926.02 |
| Education | $73.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,699.54 | 2021-2024 | |
| Janssen Biotech, INC. | $1,061.95 | 2021-2024 | Tremfya, Simponi, Stelara |
| Leo Pharma INC. | $518.75 | 2021-2024 | Adbry |
| Journey Medical Corporation | $500.00 | 2021 | |
| Genzyme Corporation | $412.42 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $245.51 | 2021-2023 | Odomzo, Blu-U |
| Novartis Pharmaceuticals Corporation | $239.45 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $228.72 | 2021-2024 | Dupixent, Libtayo |
| Lilly USA, LLC | $215.44 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $143.01 | 2022-2024 | |
| Galderma Laboratories, L.P. | $84.09 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $52.08 | 2023 | |
| Amgen INC. | $47.95 | 2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.41 | 2022-2023 | Jublia |
| Ucb, INC. | $32.64 | 2024 | Bimzelx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $26.99 | 2024 | Poteligeo |
| Arcutis Biotherapeutics, INC. | $23.56 | 2024 | Zoryve |
| Incyte Corporation | $17.13 | 2023 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.